Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricGEHCGE HealthCareRMDResMedDXCMDexcom
Snapshot
Price$71.20$213.94$83.47
Market cap$29.82B$30.41B$27.49B
Valuation
P/E17.4x20.4x34.9x
Forward P/E19.8x17.5x25x
Growth
Revenue growth6.0%10.3%16.1%
EPS growth-12.3%16.5%77.5%
Profitability
Net margin9.1%27.4%19.3%
ROE18.8%24.4%33.8%
Balance sheet & cash
Debt / equity0.97x0.11x0.47x
Free cash flow yield7.7%3.8%1.8%
Dividend yield0.2%1.2%—
Verdict
Investment ratingNeutral· 51Strong· 75Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearGEHCtoday $71RMDtoday $214DXCMtoday $83
2027$54.47 – $79.89+12% CAGR$186.88 – $274.09+28% CAGR$111.09 – $162.93+95% CAGR
2028$55.56 – $81.48+7% CAGR$217.66 – $319.24+22% CAGR$197.13 – $289.12+86% CAGR
2029$56.67 – $83.11+5% CAGR$253.51 – $371.81+20% CAGR$349.80 – $513.04+83% CAGR
2030$57.80 – $84.78+4% CAGR$295.26 – $433.05+19% CAGR$620.72 – $910.39+82% CAGR
2031$58.96 – $86.47+4% CAGR$343.89 – $504.38+19% CAGR$1,101.47 – $1,615.49+81% CAGR
5-yr CAGR-3.7% – 4.0%10.0% – 18.7%67.5% – 80.9%